Shringi Sharma

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Replacement Therapy

Regulatory T Cells

Circulating Tumor

Top Venues

British journal of clinical pharmacology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Pinkal M Desai, Sagar Lonial, Amanda F Cashen, Manali Kamdar, Ian W Flinn, Susan M O'Brien, Jacqueline S Garcia, Neha Korde, Javid J Moslehi, Margaret Wey, Patricia Cheung, Shringi Sharma, Damilola Olabode, Hong Chen, Firasath Ali Syed, Mary Liu, Marcio Andrade-Campos, Tapan Mahendra Kadia, James S Blachly
A PHASE 1 FIRST-IN-HUMAN STUDY OF THE MCL-1 INHIBITOR AZD5991 IN PATIENTS WITH RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Mark J Roschewski, Manish R Patel, Patrick M Reagan, Nakhle S Saba, Graham P Collins, Hendrick-Tobias Arkenau, Sven de Vos, Barret R B Nuttall, Melih Acar, Kathleen Burke, Rafael D White, Maria Udriste, Shringi Sharma, Brian Dougherty, Daniel Stetson, David F Jenkins, Andrew Mortlock, Alessandra Forcina, Veerendra Munugalavadla, Ian W Flinn
Phase 1 Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Julio C Chavez, Francine M Foss, Basem M William, Jonathan E Brammer, Sonali M Smith, Anca Prica, Jasmine M Zain, Joseph M Tuscano, Harsh R Shah, Neha Mehta-Shah, Praveen Ramakrishnan Ramakrishnan Geethakumari, Ben X Wang, Stephanie Zantinge, Lisa Wang, Ling Zhang, Anmarie Boutrin, Weiguang Zhao, Lily I Cheng, Nathan Standifer, Lisa Hewitt, Enowmpey Enowtambong, Weiping Shao, Shringi Sharma, Gianluca Carlesso, Jeffrey A Moscow, Lillian L Siu
Targeting the Inducible T-cell Costimulator (ICOS) in patients with Relapsed/Refractory T-Follicular Helper Phenotype Peripheral T-Cell and Angioimmunoblastic T-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Buyun Chen, Diansong Zhou, Hua Wei, Marmor Yotvat, Li Zhou, Jean Cheung, Nicole Sarvaria, Richard Lai, Shringi Sharma, Karthick Vishwanathan, Joseph Ware
Acalabrutinib CYP3A-mediated drug-drug interactions: Clinical evaluations and physiologically based pharmacokinetic modelling to inform dose adjustment strategy. British journal of clinical pharmacology 88 (8) (2022)
Shringi Sharma, Xavier Pepin, Jean Cheung, Lianqing Zheng, Hua Wei, Danielle Townsley, David Han, Michal Majewski, Joseph A Ware, James Mann, Veerendra Munugalavadla, Louise Sheridan, Priti Patel, Ashok Gupta, Helen Tomkinson
Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjects. British journal of clinical pharmacology 88 (10) (2022)
Helena Edlund, Núria Buil-Bruna, Karthick Vishwanathan, Helen Wei, Rakesh Raman, Miné de Kock, Zhongqing He, Huan Liu, Marshall Baek, Joseph Ware, Priti Patel, Helen Tomkinson, Shringi Sharma
Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignancies. British journal of clinical pharmacology (2021)
Helena Edlund, Francesco Bellanti, Huan Liu, Karthick Vishwanathan, Helen Tomkinson, Joseph Ware, Shringi Sharma, Núria Buil-Bruna
Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP-5862, in patients with B-cell malignancies and in healthy subjects using a population pharmacokinetic approach. British journal of clinical pharmacology (2021)